echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > Germany approves new new coronavirus vaccine clinical trial

    Germany approves new new coronavirus vaccine clinical trial

    • Last Update: 2020-07-11
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Paul Ehrlich Institute announced the same day, the trial of the candidate vaccine developed by the German "healing" vaccine company, is a mRNA (messenger rnaycanic acid) vaccineIts mechanism is to encode the new coronavirus sting protein messenger RNA into human cells, let the cells synthesize the virus antics protein, thereby inducing the human immune response, so that when the human body comes into contact with the real virus has an immunityAccording to the, 168 healthy volunteers participated in the first phase of the clinical trial, 144 of whom will be vaccinatedThe trial process will gradually increase the dose to confirm the general safety and tolerance of the vaccine, as well as the appropriate dose to induce the human immune responsePaul Ehrlich Institute announced on April 22nd that it had approved Germany's first clinical trial of a new coronavirus vaccine, developed by the German bio-new technology company, and is also a mRNA vaccineGermany will conduct more clinical trials of vaccines in the coming months, the institute said, and that more than one vaccine product will be needed to combat the new crown outbreak to ensure adequate supply"healing" vaccine company is currently the focus of German and EU funded vaccine research and development enterprisesThe German government has announced plans to invest 300 million euros in a "cure" vaccine company to accelerate the development of its new vaccine and treatment program.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.